Found: 84
Select item for more details and to access through your institution.
Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis.
- Published in:
- FASEB Journal, 2018, v. 32, n. 11, p. 6066, doi. 10.1096/fj.201701408R
- By:
- Publication type:
- Article
Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39581-9
- By:
- Publication type:
- Article
The long noncoding RNA Wisper controls cardiac fibrosis and remodeling.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 395, p. 1, doi. 10.1126/scitranslmed.aai9118
- By:
- Publication type:
- Article
Procollagen C-Proteinase Enhancer-1 (PCPE-1) deficiency in mice reduces liver fibrosis but not NASH progression.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0263828
- By:
- Publication type:
- Article
The Role of Circulating Biomarkers in Peripheral Arterial Disease.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 7, p. 3601, doi. 10.3390/ijms22073601
- By:
- Publication type:
- Article
Unraveling metabolism during kidney perfusion using tracer studies: a systematic review.
- Published in:
- Artificial Organs, 2022, v. 46, n. 11, p. 2118, doi. 10.1111/aor.14355
- By:
- Publication type:
- Article
Transcriptomic Analysis of Extracellular Vesicles in the Search for Novel Plasma and Thrombus Biomarkers of Ischemic Stroke Etiologies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4379, doi. 10.3390/ijms25084379
- By:
- Publication type:
- Article
Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 5, p. 817, doi. 10.1093/ndt/gfaa284
- By:
- Publication type:
- Article
ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload.
- Published in:
- Communications Biology, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s42003-022-04361-1
- By:
- Publication type:
- Article
Serum and urinary biomarkers of collagen type‐I turnover predict prognosis in patients with heart failure.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 1, p. 1, doi. 10.1002/ctm2.267
- By:
- Publication type:
- Article
Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational Study.
- Published in:
- Cerebrovascular Diseases Extra, 2023, v. 13, n. 1, p. 18, doi. 10.1159/000529067
- By:
- Publication type:
- Article
Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1231, doi. 10.1002/ejhf.3202
- By:
- Publication type:
- Article
A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: Findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1284, doi. 10.1002/ejhf.2859
- By:
- Publication type:
- Article
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1767, doi. 10.1002/ejhf.2675
- By:
- Publication type:
- Article
Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1751, doi. 10.1002/ejhf.2664
- By:
- Publication type:
- Article
The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1559, doi. 10.1002/ejhf.2579
- By:
- Publication type:
- Article
Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 944, doi. 10.1002/ejhf.2522
- By:
- Publication type:
- Article
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 927, doi. 10.1002/ejhf.2493
- By:
- Publication type:
- Article
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 771, doi. 10.1002/ejhf.2455
- By:
- Publication type:
- Article
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Urinary peptides in heart failure: a link to molecular pathophysiology.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 11, p. 1875, doi. 10.1002/ejhf.2195
- By:
- Publication type:
- Article
The 'Peptide for Life' Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across Europe.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1432, doi. 10.1002/ejhf.2293
- By:
- Publication type:
- Article
The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 6, p. 933, doi. 10.1002/ejhf.2201
- By:
- Publication type:
- Article
Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 9, p. 1711, doi. 10.1002/ejhf.1716
- By:
- Publication type:
- Article
Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Investigating a biomarker‐driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C‐terminal propeptide of procollagen type I (DROP‐PIP trial)
- Published in:
- 2018
- By:
- Publication type:
- journal article
Myocardial fibrosis: biomedical research from bench to bedside.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.
- Published in:
- European Journal of Heart Failure, 2015, v. 17, n. 8, p. 764, doi. 10.1002/ejhf.312
- By:
- Publication type:
- Article
Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
- Published in:
- European Journal of Heart Failure, 2015, v. 17, n. 4, p. 385, doi. 10.1002/ejhf.246
- By:
- Publication type:
- Article
Myocardial fibrosis: biomedical research from bench to bedside.
- Published in:
- European Journal of Heart Failure. Supplements, 2017, v. 19, n. 2, p. 177, doi. 10.1002/ejhf.696
- By:
- Publication type:
- Article
Increased Fibroblast Growth Factor 23 in Heart Failure: Biomarker, Mechanism, or Both?
- Published in:
- American Journal of Hypertension, 2019, v. 32, n. 1, p. 15, doi. 10.1093/ajh/hpy153
- By:
- Publication type:
- Article
Myocardial COX-2 overexpression and fibrosis in hypertensive heart disease. Role of angiotensin II
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Plasma cardiotrophin-1, a myocardial stress marker in hypertensive heart disease ?
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Biochemical monitoring of myocardial fibrosis in hypertensive patients with heart failure
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Association between a deficient cardiotrophin-1 signaling pathway and cardiac apoptosis in genetic hypertension
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Myocardial fibrosis determines left ventricular chamber stiffness in hypertensive patients. Effects of treatment with losartan
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action.
- Published in:
- Nefrologia, 2020, v. 40, n. 3, p. 223, doi. 10.1016/j.nefro.2019.10.005
- By:
- Publication type:
- Article
Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide: New strategies to prevent cardiovascular risk in chronic kidney disease.
- Published in:
- Kidney International, 2008, v. 74, p. S19, doi. 10.1038/ki.2008.512
- By:
- Publication type:
- Article
Cardiotrophin-1 in hypertensive heart disease.
- Published in:
- Endocrine (1355008X), 2012, v. 42, n. 1, p. 9, doi. 10.1007/s12020-012-9649-4
- By:
- Publication type:
- Article
Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities.
- Published in:
- Basic Research in Cardiology, 2020, v. 115, n. 4, p. 1, doi. 10.1007/s00395-020-0798-y
- By:
- Publication type:
- Article
Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.
- Published in:
- Scientific Reports, 2017, p. 41865, doi. 10.1038/srep41865
- By:
- Publication type:
- Article
MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure.
- Published in:
- Scientific Reports, 2017, p. 40696, doi. 10.1038/srep40696
- By:
- Publication type:
- Article
En la materia del mundo. Apuntes sobre la escultura hindú.
- Published in:
- Anales de Historia del Arte, 2021, v. 31, p. 467, doi. 10.5209/anha.78069
- By:
- Publication type:
- Article
ABC. El alfabeto del Museo de Bilbao.
- Published in:
- Anales de Historia del Arte, 2019, v. 29, p. 459, doi. 10.5209/anha.66071
- By:
- Publication type:
- Article
H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13148-020-00895-5
- By:
- Publication type:
- Article
Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance.
- Published in:
- Journal of Cardiovascular Magnetic Resonance (BioMed Central), 2020, v. 22, n. 1, p. 1, doi. 10.1186/s12968-020-00674-4
- By:
- Publication type:
- Article
Effectiveness and cost-effectiveness of a multicomponent intervention to implement a clinical practice guideline for systemic lupus erythematosus: protocol for a cluster-randomized controlled trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dyskalemia in people at increased risk for heart failure: findings from the heart 'OMics' in AGEing (HOMAGE) trial.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 6, p. 4352, doi. 10.1002/ehf2.14086
- By:
- Publication type:
- Article
Impact analysis of heart failure across European countries: an ESC‐HFA position paper.
- Published in:
- ESC Heart Failure, 2022, v. 9, n. 5, p. 2767, doi. 10.1002/ehf2.14076
- By:
- Publication type:
- Article